1. Home
  2. News
  3. Venmax Drugs & Pharmaceuticals Ltd.
  4. Announcement under Regulation 30 (LODR)-Resignation of Director
More Venmax Drugs & Pharmaceuticals Ltd. news
Venmax Drugs & Pharmaceuticals Ltd.BSE: VENMAX

Announcement under Regulation 30 (LODR)-Resignation of Director

Nov 24, 2025 at 9:14 AM EST · Issued by Venmax Drugs & Pharmaceuticals Ltd. via BSE India

Filed with BSE · Nov 24, 2025 at 9:14 AM EST · 4 pages · English

On 6ix: 6ix.com/news/announcement-under-regulation-30-lodr-resignation-of-director-133

Venmax Drugs & Pharmaceuticals Ltd. on 6ix

Earlier from Venmax Drugs & Pharmaceuticals

  • Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 14 2025Nov 14, 2025
  • Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 14, 2025
  • Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 12 2025Nov 12, 2025
  • Unaudited Financial Results For The Quarter And Half Year Ended September 30, 2025.Nov 12, 2025
  • Board Meeting Outcome for Outcome Of The Board MeetingNov 12, 2025

Later from Venmax Drugs & Pharmaceuticals

  • Venmax Drugs & Pharmaceuticals Ltd. Press Release Nov 25 2025Nov 25, 2025
  • Closure of Trading WindowDec 26, 2025
  • Venmax Drugs & Pharmaceuticals Ltd. Press Release Dec 26 2025Dec 26, 2025
  • Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018Jan 12
  • Venmax Drugs & Pharmaceuticals Ltd. Press Release Jan 12 2026Jan 12
All Venmax Drugs & Pharmaceuticals news releases↗

Follow Venmax Drugs & Pharmaceuticals into a list and get an email when it puts out news.

Follow Venmax Drugs & Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer